Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Announcement QUEST

Reminder For Successful Payment Status

Please note that for all payments made in QUEST 3+, due to manual back-end processing including verification of the online payments received, you may check the status of your payment(s) and status of…

Announcement QUEST

Update on E.13 Field for Approved Product

Quest 3 + (E.13 Submission for Data Cleaning) For the purpose of data cleaning and E.13 update on approved product Applicant should submit the documents by separating the documents based on test…

Direct healthcare professional communications (DHPC)

ESMYA® 5 mg tablets (ulipristal acetate): Women taking Esmya® for uterine fibroids to have regular liver tests while safety review is ongoing; do not initiate treatment in new patients or those who have completed a previous treatment course

Date: 12 April 2018 Description: The Pharmacovigilance Risk Assessment Committee (PRAC), European Medicines Agency (EMA) started a review of Esmya®, to assess the link between Esmya® and cases of…

Announcement - General

National Regulatory Conference (NRC) 2018

National Regulatory Conference (NRC) 2018 Tuesday, 2 October 2018 until Thursday, 4 October 2018 Theme :Regulatory Excellence : The New Normal Venue : Hotel Royale Chulan Damansara, Selangor Contact…

Document attached

Announcement

MAKLUMAN SCAM PANGGILAN TELEFON

Sejak kebelakangan ini, Bahagian Regulatori Farmasi Negara (NPRA) telah menerima laporan berkaitan kes penipuan atau scam menggunakan panggilan telefon. Didapati bahawa terdapat pelanggan NPRA yang…

Announcement

New Safety Alerts for Healthcare Professionals

New Safety Alerts Update : Levetiracetam and Methotrexate: Risk of Drug-drug Interaction Intravenous (IV) Fluids Containing Electrolytes and/or Carbohydrates: Risk of Hyponatraemia Gadolinium-based…

Safety Alert

Doxycycline: Risk of Jarisch-Herxheimer reaction

Background The National Pharmaceutical Regulatory Agency (NPRA) received information from the European Medicines Agency (EMA) on the risk of Jarisch-Herxheimer reaction (JHR) with doxycycline. The…

Document attached

Announcement

QUEST3+ System USB token package

MSC Trustgate USB token package with 3 years validity will be no longer offered. For more information, kindly contact MSC Trustgate Customer Care at 03-8318 1800. * Price stated in bracket inclusive…

Announcement

Application Of Combination Pack (Combo Pack)

For a combination pack consists of registered products from different product owners/PRH, the application need to be submitted manually (please use the application form NPRA 500CP). 1. Applicant to…